DEFECTIVE MACROPHAGE MIGRATION PRODUCED BY NEOPLASMS: IDENTIFICATION OF AN INHIBITOR OF MACROPHAGE CHEMOTAXIS1
暂无分享,去创建一个
[1] R. Snyderman,et al. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. , 1976, Journal of immunology.
[2] M. R. Mickey,et al. Defective monocyte function in patients with genitourinary carcinoma. , 1975, Journal of the National Cancer Institute.
[3] M. Smith,et al. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts. , 1975, Journal of immunology.
[4] R. Snyderman,et al. Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity , 1975, Infection and immunity.
[5] R. Snyderman,et al. Depression of macrophage chemotaxis in vivo in tumor bearing mice. , 1975 .
[6] F. Jacob,et al. Antiinflammatory effects of murine malignant cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Lala. DYNAMICS OF LEUKOCYTE MIGRATION INTO THE MOUSE ASCITES TUMOR , 1974, Cell and tissue kinetics.
[8] E. Leonard,et al. Abnormal monocyte chemotactic response in cancer patients. , 1974, Journal of the National Cancer Institute.
[9] P. Ward,et al. Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. , 1974, The New England journal of medicine.
[10] J. Cerottini,et al. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. , 1974, Advances in immunology.
[11] E. Wheelock,et al. The role of macrophages in defense against neoplastic disease. , 1974, Advances in cancer research.
[12] I. Bernstein. Immunologic defenses against cancer. , 1973, The Journal of pediatrics.
[13] R. Snyderman,et al. A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. , 1973, Journal of immunology.
[14] R. Snyderman,et al. Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. , 1972, Journal of immunology.
[15] D. Nelson,et al. Macrophages As Effectors Of Cell-Mediated Immunity , 2020, Phagocytes and Cellular Immunity.
[16] R. Snyderman,et al. BIOLOGICAL ACTIVITY OF COMPLEMENT IN VIVO , 1971, The Journal of experimental medicine.
[17] B. Zbar,et al. Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils. , 1970, Journal of the National Cancer Institute.
[18] K. Hellström,et al. Immunological enhancement as studied by cell culture techniques. , 1970, Annual review of microbiology.
[19] Graham Jb,et al. TOLERANCE AGENT IN HUMAN CANCER. , 1964 .